NCT05745389 CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry Status RECRUITING Phase N/A
NCT05650333 A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age Status COMPLETED Phase PHASE1
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05600673 Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata Status COMPLETED Phase PHASE1/PHASE2
NCT05599607 Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata Status COMPLETED Phase NA
NCT05589610 Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata Status COMPLETED Phase PHASE2
NCT05588310 Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors Status UNKNOWN Phase N/A
NCT05587257 Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata Status UNKNOWN Phase NA
NCT05556265 A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata Status TERMINATED Phase PHASE2
NCT05522556 Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600) Status AVAILABLE Phase N/A
NCT05502952 Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative Study Status UNKNOWN Phase NA
NCT05485571 Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata Status UNKNOWN Phase NA
NCT05470413 Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata Status UNKNOWN Phase PHASE3
NCT05414266 Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata Status UNKNOWN Phase EARLY_PHASE1
NCT05398809 Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata Status RECRUITING Phase PHASE2